Holen Sie sich die Stockscreener-App
4.18
2.34%
-0.10
Handel nachbörslich:
4.18
Finanzdaten der Titan Pharmaceuticals Inc De-Aktie (TTNP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
23.03%
0.657
|
0.534 | 0.666 | 0.754 | 2.074 |
| Operating Income/Loss |
23.03%
-0.657
|
-0.534 | -0.666 | -0.754 | -2.074 |
| Nonoperating Income/Loss |
10.34%
-0.032
|
-0.029 | -0.124 | -0.009 | -0.019 |
| Income/Loss From Continuing Operations Before Tax |
22.38%
-0.689
|
-0.563 | -0.789 | -0.763 | -2.093 |
| Income/Loss From Continuing Operations After Tax |
22.38%
-0.689
|
-0.563 | -0.79 | -0.763 | -2.093 |
Net Income/Loss
|
22.38%
-0.689
|
-0.563 | -0.79 | -0.763 | -2.093 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
16.52%
1.065
|
0.914 | 0.005 | 0.914 | 0.914 |
| Diluted Average Shares |
16.52%
1.065
|
0.914 | 0.005 | 0.914 | 0.914 |
| Basic Earnings Per Share |
4.84%
-0.65
|
-0.62 | -0.85 | -0.83 | -2.29 |
| Diluted Earnings Per Share |
4.84%
-0.65
|
-0.62 | -0.85 | -0.83 | -2.29 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):